Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
The Institute For Transfusion Medicine history
The Institute For Transfusion Medicine company history timeline
1987 Two tests that screen for indirect evidence of hepatitis are developed and implemented, hepatitis B core antibody (anti-HBc) and the alanine aminotransferase test (ALT).
1990 Introduction of first specific test for hepatitis C, the major cause of “non-A, non-B” hepatitis.
1996 HIV p24 antigen testing of donated blood begins.
1999 Blood establishments begin using nucleic acid amplification testing (NAT) under FDA’s Investigational New Drug (IND) program; NAT employs testing technology that directly detects genetic materials from viruses, including HCV and HIV.
2004 AABB receives $2.4 Million CDC grant to reduce transfusion-transmitted HIV in Africa and South America.
2005 AABB founding member Tibor Greenwalt dies.
2006 AABB starts collaborating with Centers for Disease Control and Prevention to create CDC National Healthcare Safety Network Hemovigilance Module.
2017 FDA approves first two chimeric antigen receptor (CAR) T cell therapies to treat cancer.
IHTM accomplishments were further reflected in the Rzeczpospolita 2018- ranking; IHTM ranked first in Poland in monospecialist hospitals in Poland and second in hospitals of the Mazowsze region.
Rate The Institute For Transfusion Medicine's efforts to communicate its history to employees.
The Institute For Transfusion Medicine jobs
Do you work at The Institute For Transfusion Medicine?
Is The Institute For Transfusion Medicine's vision a big part of strategic planning?
The Institute For Transfusion Medicine history FAQs
Zippia gives an in-depth look into the details of The Institute For Transfusion Medicine, including salaries, political affiliations, employee data, and more, in order to inform job seekers about The Institute For Transfusion Medicine. The employee data is based on information from people who have self-reported their past or current employments at The Institute For Transfusion Medicine. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by The Institute For Transfusion Medicine. The data presented on this page does not represent the view of The Institute For Transfusion Medicine and its employees or that of Zippia.
The Institute For Transfusion Medicine may also be known as or be related to Institute For Transfusion Medicine The, THE SUBSIDIARIES OF THE INSTITUTE, The Institute For Transfusion Medicine, The Institute for Transfusion Medicine Inc and The Institute for Transfusion Medicine Inc.